The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.

MLA

Koo, Jamie, et al. “The Immunohistochemical Expression of Islet 1 and PAX8 by Rectal Neuroendocrine Tumors Should Be Taken into Account in the Differential Diagnosis of Metastatic Neuroendocrine Tumors of Unknown Primary Origin.” Endocrine Pathology, vol. 24, no. 4, Dec. 2013, pp. 184–90. EBSCOhost, https://doi.org/10.1007/s12022-013-9264-9.

APA

Koo, J., Zhou, X., Moschiano, E., De Peralta-Venturina, M., Mertens, R. B., & Dhall, D. (2013). The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin. Endocrine Pathology, 24(4), 184–190. https://doi.org/10.1007/s12022-013-9264-9

Chicago

Koo, Jamie, Xiaoyan Zhou, Elizabeth Moschiano, Mariza De Peralta-Venturina, Richard B Mertens, and Deepti Dhall. 2013. “The Immunohistochemical Expression of Islet 1 and PAX8 by Rectal Neuroendocrine Tumors Should Be Taken into Account in the Differential Diagnosis of Metastatic Neuroendocrine Tumors of Unknown Primary Origin.” Endocrine Pathology 24 (4): 184–90. doi:10.1007/s12022-013-9264-9.